| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 44.291 | 24 |
| GSM780708 | Untreated after 4 days (C2_1) | 39.8342 | 6 |
| GSM780709 | Untreated after 4 days (C3_1) | 48.1929 | 42 |
| GSM780719 | Untreated after 4 days (C1_2) | 42.0962 | 13 |
| GSM780720 | Untreated after 4 days (C2_2) | 44.6869 | 26 |
| GSM780721 | Untreated after 4 days (C3_2) | 45.7699 | 31 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 45.4934 | 30 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 47.3763 | 38 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 39.9133 | 6 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 43.5644 | 20 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 48.9886 | 45 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 48.0103 | 41 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 48.3695 | 43 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 48.3101 | 42 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 39.9592 | 6 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 43.6631 | 21 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 45.933 | 32 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 41.0593 | 10 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 46.9259 | 36 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 47.1614 | 37 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 47.0881 | 37 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 45.9051 | 32 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 37.0933 | 2 |